Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Drugs Aging. 2017 Jan;34(1):55–65. doi: 10.1007/s40266-016-0419-5

Table 2. Cohort-specific characteristics at the index date.

Baseline characteristicsa Male, N (%) Female, N (%)b p value
US cohort
 Race 0.032
  White 446 (88.8) 491 (82.2)
  Black 34 (6.8) 65 (10.9)
  Other 22 (4.4) 41 (6.9)
 Education <0.001
  High school or less 111 (22.21) 203 (34.0)
  College 189 (37.95) 244 (40.87)
  Graduate 202 (40.24) 150 (25.13)
 Living situation <0.001
  Lives alone 49 (9.8) 214 (35.8)
  Lives with spouse or partner 408 (81.3) 256 (42.9)
  Other living arrangements 45 (9.0) 127 (21.3)
 Type of residence 0.017
  Single family residence 439 (87.5) 485 (81.2)
  Retirement community 38 (7.6) 55 (9.2)
  Assisted livinga 19 (3.8) 47 (7.9)
  Other 6 (1.2) 10 (1.7)
 Level of independence 0.651
  Able to live independently 184 (36.7) 199 (33.3)
  Requires some assistance with complex activities 247 (49.2) 297 (49.7)
  Requires some assistance with basic activities 60 (12.0) 88 (14.7)
  Completely dependent 11 (2.2) 13 (2.2)
 BMI <0.001
  Mean (SD) 25.8 (3.63) 24.6 (4.72)
  Q1, median, Q3 23, 25, 28 21, 24, 27
 BMI categories <0.001
  Obese 64 (14.4) 68 (13.6)
 Global clinical dementia rating 0.776
  No impairment 0 (0) 0 (0)
  Questionable impairment 272 (54.2) 327 (54.8)
  Mild impairment 207 (41.2) 237 (39.7)
  Moderate/severe impairment 23 (4.6) 33 (5.5)
 MMSE category 0.232
  Normal 112 (23.0) 119 (21.3)
  Mild 277 (57.0) 348 (62.4)
  Moderate 81 (16.7) 72 (12.9)
  Severe 2 (0.4) 3 (0.5)
  Unknown 14 (2.9) 16 (2.9)
 Behavioral symptoms
  Delusions 36 (7.4) 50 (8.6) 0.481
  Hallucinations 11 (2.3) 21 (3.6) 0.199
  Agitation or aggression 137 (28.3) 158 (27.2) 0.693
  Depression or dysphoria 157 (32.4) 231 (39.8) 0.013
  Anxiety 157 (32.4) 178 (30.7) 0.541
 Geriatric Depression Scale score categories 0.616
  0–4 405 (84.2) 455 (81.1)
  5–9 59 (12.3) 84 (15.0)
  10–15 9 (1.9) 12 (2.1)
  Unknown 8 (1.7) 10 (1.8)
 Co-morbidities
  Depression within the past 2 years 178 (35.5) 279 (46.7) <0.001
  Psychiatric disorders 29 (5.8) 53 (8.9) 0.051
  Transient ischemic attack 33 (6.6) 44 (7.4) 0.606
  Incontinence: urinary 84 (16.7) 150 (25.1) <0.001
 Apolipoprotein e4 alleles 0.119
  No e4 allele 196 (39.0) 214 (35.8)
  Any copy of e4 allele 225 (44.8) 258 (43.2)
Finnish cohort
 Occupational socioeconomic position <0.001
  Office worker 714 (3.1; 2.9–3.3) 4954 (11.2; 11.0–11.5)
  Farming/forestry 5195 (22.6; 22.1–23.2) 7748 (17.6; 17.2 –17.9)
  Sales/industry/cleaning 10,528 (45.9; 45.2–46.5) 18,228 (41.3; 40.9–41.8)
  Unknown 245 (1.1; 0.9–1.2) 5318 (12.1; 11.8–12.4)
  Did not respond 159 (0.7; 0.6–0.8) 353 (0.8; 0.7–0.9)
 Co-morbidities
  Asthma/COPD 2077 (9.1; 8.7–9.4) 3908 (8.9; 8.6–9.1) 0.434
  Rheumatoid arthritis 750 (3.3; 3.0–3.5) 2319 (5.3; 5.1–5.5) <0.001
  History of hip fracture 764 (3.3; 3.1–3.6) 3351 (7.6; 7.4–7.9) <0.001
  Hospital-treated depression 519 (2.3; 2.1–2.5) 1700 (3.9; 3.7–4.1)

BMI body mass index, CI confidence interval, COPD chronic obstructive pulmonary disorder, MMSE Mini-Mental State Examination, SD standard deviation

a

Columns display N (%), unless otherwise specified

b

For the Finnish cohort, table includes N (%) with 95% CI for %